Akari Therapeutics Plc·4

Dec 27, 4:30 PM ET

Patel Samir Rashmikant 4

4 · Akari Therapeutics Plc · Filed Dec 27, 2024

Insider Transaction Report

Form 4
Period: 2024-12-24
Transactions
  • Award

    Ordinary Shares, par value $0.0001 per share

    2024-12-24$0.00/sh+7,500,000$3,7505,245,703,500 total(indirect: By LLC)
Holdings
  • Ordinary Shares, par value $0.0001 per share

    91,396,000
Footnotes (2)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
  • [F2]On December 24, 2024, the Reporting Person acquired 7,500,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4